0.3794
price down icon6.48%   -0.0263
after-market アフターアワーズ: .41 0.0306 +8.07%
loading
前日終値:
$0.4057
開ける:
$0.3986
24時間の取引高:
830.48K
Relative Volume:
0.39
時価総額:
$71.29M
収益:
当期純損益:
$-222.39M
株価収益率:
-0.286
EPS:
-1.3268
ネットキャッシュフロー:
$-193.40M
1週間 パフォーマンス:
-19.92%
1か月 パフォーマンス:
-48.12%
6か月 パフォーマンス:
-82.99%
1年 パフォーマンス:
-83.58%
1日の値動き範囲:
Value
$0.3658
$0.414
1週間の範囲:
Value
$0.3658
$0.5049
52週間の値動き範囲:
Value
$0.3154
$3.65

Neumora Therapeutics Inc Stock (NMRA) Company Profile

Name
名前
Neumora Therapeutics Inc
Name
セクター
Healthcare (1052)
Name
電話
(857) 760-0900
Name
住所
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Name
職員
96
Name
Twitter
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
NMRA's Discussions on Twitter

Compare NMRA vs VRTX, REGN, MRNA, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
NMRA icon
NMRA
Neumora Therapeutics Inc
0.3794 71.29M 0 -222.39M -193.40M -1.3268
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
523.93 132.80B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
805.02 82.88B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
200.10 79.89B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
873.71 54.94B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
377.63 42.72B 5.76B 514.49M 1.10B 4.4813

Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-06-16 繰り返されました H.C. Wainwright Buy
2026-06-16 繰り返されました Needham Buy
2026-02-17 アップグレード William Blair Mkt Perform → Outperform
2026-01-12 開始されました Leerink Partners Outperform
2025-12-01 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-10-27 アップグレード Guggenheim Neutral → Buy
2025-09-16 ダウングレード JP Morgan Neutral → Underweight
2025-04-02 ダウングレード BofA Securities Buy → Underperform
2025-03-10 ダウングレード William Blair Outperform → Mkt Perform
2025-03-07 ダウングレード Guggenheim Buy → Neutral
2025-03-07 ダウングレード Stifel Buy → Hold
2025-01-02 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-11-05 ダウングレード JP Morgan Overweight → Neutral
2024-10-01 開始されました H.C. Wainwright Buy
2024-07-22 開始されました Needham Buy
2024-07-08 開始されました Mizuho Outperform
2023-12-12 開始されました Deutsche Bank Hold
2023-10-10 開始されました BofA Securities Buy
2023-10-10 開始されました Guggenheim Buy
2023-10-10 開始されました JP Morgan Overweight
2023-10-10 開始されました RBC Capital Mkts Outperform
2023-10-10 開始されました Stifel Buy
2023-10-10 開始されました William Blair Outperform
すべてを表示

Neumora Therapeutics Inc (NMRA) 最新ニュース

pulisher
Oct 14, 2026

Neumora Therapeutics, Inc. (NMRA)What Are Researchers Thinking About This Stock? - MarketBeat

Oct 14, 2026
pulisher
Sep 21, 2026

Neumora Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your RightsNMRA - ACCESS Newswire

Sep 21, 2026
pulisher
Sep 19, 2026

What’s Behind Neumora Therapeutics (NASDAQ:NMRA) Now? - kalkinemedia.com

Sep 19, 2026
pulisher
Sep 19, 2026

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 19, 2026
pulisher
Sep 05, 2026

MU: Micron Technology Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 05, 2026
pulisher
Sep 04, 2026

BlackRock Inc. Buys Shares of 7,791,869 Neumora Therapeutics, Inc. $NMRA - MarketBeat

Sep 04, 2026
pulisher
Sep 02, 2026

Greg Tourangeau, Former Fulcrum Therapeutics Officer, to Sell 14,062 Shares Worth $54,420 - kalkinemedia.com

Sep 02, 2026
pulisher
Aug 29, 2026

Insiders Sold Neumora Therapeutics Prematurely At US$2.29 With Stock Trading Higher - simplywall.st

Aug 29, 2026
pulisher
Aug 25, 2026

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Aug 25, 2026
pulisher
Aug 24, 2026

2,559,090 Shares in Neumora Therapeutics, Inc. $NMRA Purchased by ICONIQ Capital LLC - MarketBeat

Aug 24, 2026
pulisher
Aug 22, 2026

Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com India

Aug 22, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com

Aug 21, 2026
pulisher
Aug 21, 2026

Daljit Singh Aurora Sells 21,055 Shares of Neumora Therapeutics (NASDAQ:NMRA) Stock - MarketBeat

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh - Moomoo

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics (NMRA) grants chair 500K stock options - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics (NASDAQ: NMRA) officer plans 41,608-share sale after August trades - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Neumora Therapeutics (NMRA) grants CEO 500K stock options - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Mizuho maintains Outperform on Neumora, cuts target to $4 - scanx.trade

Aug 21, 2026
pulisher
Aug 20, 2026

Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 20, 2026
pulisher
Aug 20, 2026

Neumora (NASDAQ: NMRA) officer plans cashless sale of 134K shares - Stock Titan

Aug 20, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock - Investing.com

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com South Africa

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com Nigeria

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com India

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com Canada

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 31,000 Shares - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 34,987 Shares - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh - Moomoo

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics (NMRA) insider plans new stock sale after $329K in recent trades - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Q3 EPS Estimate for Neumora Therapeutics Lifted by Analyst - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

Neumora Therapeutics, Inc. Stock 12‑Month Price Target Raised to $6.67, Implies 307% Upside - TradingView

Aug 19, 2026
pulisher
Aug 18, 2026

Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 18, 2026
pulisher
Aug 18, 2026

Neumora (NASDAQ: NMRA) insider to sell 69K more shares - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

Neumora Therapeutics, Inc. (NMRA) Receives a Buy from RBC Capital - The Globe and Mail

Aug 18, 2026
pulisher
Aug 17, 2026

Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Aug 17, 2026
pulisher
Aug 17, 2026

Neumora Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Aug 17, 2026
pulisher
Aug 17, 2026

Neumora (NASDAQ: NMRA) to sell 146K shares via Merrill Lynch - Stock Titan

Aug 17, 2026
pulisher
Aug 17, 2026

Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Aug 17, 2026
pulisher
Aug 17, 2026

H.C. Wainwright Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $7 - Moomoo

Aug 17, 2026
pulisher
Aug 16, 2026

1,849,445 Shares in Neumora Therapeutics, Inc. $NMRA Purchased by Johnson & Johnson - MarketBeat

Aug 16, 2026
pulisher
Aug 15, 2026

RBC Capital maintains Outperform on Neumora, cuts target to $5 - scanx.trade

Aug 15, 2026
pulisher
Aug 15, 2026

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS) - The Globe and Mail

Aug 15, 2026
pulisher
Aug 15, 2026

Neumora Therapeutics (NASDAQ:NMRA) Upgraded at Wall Street Zen - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Neumora Therapeutics (NASDAQ:NMRA) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Aug 14, 2026
pulisher
Aug 14, 2026

Neumora Therapeutics Releases Q2 2026 Financial Results - AlphaStreet

Aug 14, 2026
pulisher
Aug 14, 2026

8-K: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updatemoomoo - moomoo.com

Aug 14, 2026
pulisher
Aug 14, 2026

Neumora Therapeutics Appoints Joshua Pinto as CEO and Releases Q2 2026 Financial Results - Kalkine Media

Aug 14, 2026
pulisher
Aug 14, 2026

Neumora Therapeutics Cuts Q2 Net Loss to $41.3M on Lower R&D Spend - Minichart

Aug 14, 2026

Neumora Therapeutics Inc (NMRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Neumora Therapeutics Inc (NMRA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Aurora Daljit Singh
See Remarks
Aug 21 '26
Sale
1.60
21,055
33,600
0
Aurora Daljit Singh
See Remarks
Aug 21 '26
Option Exercise
0.72
20,553
14,798
69,303
Aurora Daljit Singh
See Remarks
Aug 21 '26
Option Exercise
0.72
21,055
15,160
21,055
Aurora Daljit Singh
See Remarks
Aug 21 '26
Sale
1.59
20,553
32,780
48,750
Aurora Daljit Singh
Officer
Aug 21 '26
Proposed Sale
1.60
41,608
66,380
0
Aurora Daljit Singh
See Remarks
Aug 20 '26
Option Exercise
0.72
66,711
48,032
66,711
Aurora Daljit Singh
See Remarks
Aug 20 '26
Sale
1.51
66,711
101,000
0
Aurora Daljit Singh
Officer
Aug 20 '26
Proposed Sale
1.51
134,452
203,584
0
Aurora Daljit Singh
See Remarks
Aug 20 '26
Sale
1.51
67,741
102,587
48,750
Aurora Daljit Singh
Officer
Aug 19 '26
Proposed Sale
1.65
61,918
101,917
0
$7.85
price down icon 3.09%
$9.75
price up icon 0.72%
$8.03
price down icon 4.18%
$5.85
price down icon 0.17%
WVE WVE
$3.18
price down icon 5.07%
$13.83
price down icon 4.62%
大文字化:     |  ボリューム (24 時間):